Showing 1 to 5 of 5 results
EU Deadlocked on Pharmaceutical Data Protection Reform
Poland's attempt to shorten pharmaceutical data protection in the EU to seven years, supported by a dozen smaller countries, failed due to opposition from larger countries prioritizing eight years to boost competitiveness, creating a deadlock that affects patient access to affordable medicines.
EU Deadlocked on Pharmaceutical Data Protection Reform
Poland's attempt to shorten pharmaceutical data protection in the EU to seven years, supported by a dozen smaller countries, failed due to opposition from larger countries prioritizing eight years to boost competitiveness, creating a deadlock that affects patient access to affordable medicines.
Progress
44% Bias Score
RFK Jr. and Sanders Clash During Heated HHS Confirmation Hearing
During his HHS confirmation hearing, Robert F. Kennedy Jr. clashed with Senator Bernie Sanders over campaign finance and healthcare policy, accusing Sanders of accepting pharmaceutical money while Sanders countered with claims of donations from workers, not corporate PACs, and highlighted his record...
RFK Jr. and Sanders Clash During Heated HHS Confirmation Hearing
During his HHS confirmation hearing, Robert F. Kennedy Jr. clashed with Senator Bernie Sanders over campaign finance and healthcare policy, accusing Sanders of accepting pharmaceutical money while Sanders countered with claims of donations from workers, not corporate PACs, and highlighted his record...
Progress
44% Bias Score
Healthcare Industry Under Fire After CEO's Death
The murder of UnitedHealthcare CEO Brian Thompson sparked increased scrutiny of the U.S. healthcare industry, revealing high costs, denied claims, and prompting investigations into large conglomerates and their pharmacy benefit managers by lawmakers amid declining profits and investor concerns.
Healthcare Industry Under Fire After CEO's Death
The murder of UnitedHealthcare CEO Brian Thompson sparked increased scrutiny of the U.S. healthcare industry, revealing high costs, denied claims, and prompting investigations into large conglomerates and their pharmacy benefit managers by lawmakers amid declining profits and investor concerns.
Progress
56% Bias Score
Australia Defends PBS Subsidies Amidst US Tariff Threats
Australia will maintain its Pharmaceutical Benefits Scheme (PBS) subsidies despite threats of US tariffs on pharmaceutical exports, implementing a $25 cap on prescription medicine if re-elected. The US drug companies argue that Australia's PBS is discriminatory, but Australia counters that maintaini...
Australia Defends PBS Subsidies Amidst US Tariff Threats
Australia will maintain its Pharmaceutical Benefits Scheme (PBS) subsidies despite threats of US tariffs on pharmaceutical exports, implementing a $25 cap on prescription medicine if re-elected. The US drug companies argue that Australia's PBS is discriminatory, but Australia counters that maintaini...
Progress
56% Bias Score
Trump, Congress Threaten Health Care Company Regulation Amidst Consumer Outrage
President-elect Trump and Congress are threatening increased regulation of large health care companies like UnitedHealth, CVS, and Cigna, following consumer anger over high costs and claim denials; these companies control 80% of U.S. prescriptions through pharmacy benefit managers.
Trump, Congress Threaten Health Care Company Regulation Amidst Consumer Outrage
President-elect Trump and Congress are threatening increased regulation of large health care companies like UnitedHealth, CVS, and Cigna, following consumer anger over high costs and claim denials; these companies control 80% of U.S. prescriptions through pharmacy benefit managers.
Progress
56% Bias Score
Showing 1 to 5 of 5 results